Edgewise Therapeutics (EWTX) Earnings Date & Reports
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
EWTX is expected to report earnings to rise 3.26% to -47 cents per share on August 06
Q2'26
Est.
$-0.47
Q1'26
Beat
by $0.03
Q4'25
Missed
by $0.03
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.08
The last earnings report on May 07 showed earnings per share of -46 cents, beating the estimate of -49 cents. With 1.23M shares outstanding, the current market capitalization sits at 3.66B.